253 related articles for article (PubMed ID: 33230459)
1. ATF2-Induced lncRNA GAS8-AS1 Promotes Autophagy of Thyroid Cancer Cells by Targeting the miR-187-3p/ATG5 and miR-1343-3p/ATG7 Axes.
Qin Y; Sun W; Wang Z; Dong W; He L; Zhang T; Shao L; Zhang H
Mol Ther Nucleic Acids; 2020 Dec; 22():584-600. PubMed ID: 33230459
[TBL] [Abstract][Full Text] [Related]
2. LncRNA GAS8-AS1 inhibits cell proliferation through ATG5-mediated autophagy in papillary thyroid cancer.
Qin Y; Sun W; Zhang H; Zhang P; Wang Z; Dong W; He L; Zhang T; Shao L; Zhang W; Wu C
Endocrine; 2018 Mar; 59(3):555-564. PubMed ID: 29327301
[TBL] [Abstract][Full Text] [Related]
3. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.
Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q
Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221
[TBL] [Abstract][Full Text] [Related]
4. lncRNA GAS8-AS1 regulates cancer cell proliferation and predicts poor survival of patients with gastric cancer.
Li C; Wang H; Meng S; Hong J; Yao L; Shao Y; Zhu X
Oncol Lett; 2022 Feb; 23(2):48. PubMed ID: 34992681
[TBL] [Abstract][Full Text] [Related]
5. LncRNA GAS8-AS1 suppresses papillary thyroid carcinoma cell growth through the miR-135b-5p/CCND2 axis.
Chen N; Yin D; Lun B; Guo X
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30429236
[TBL] [Abstract][Full Text] [Related]
6. Plasma lncRNA GAS8-AS1 as a Potential Biomarker of Papillary Thyroid Carcinoma in Chinese Patients.
Zhang D; Liu X; Wei B; Qiao G; Jiang T; Chen Z
Int J Endocrinol; 2017; 2017():2645904. PubMed ID: 28781594
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
[TBL] [Abstract][Full Text] [Related]
8.
Song Z; Han Q; Wen Z; Lv Q; Pan C; Pan Y
Ann Transl Med; 2023 Feb; 11(3):143. PubMed ID: 36846012
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA MFSD4A-AS1 promotes lymphangiogenesis and lymphatic metastasis of papillary thyroid cancer.
Liu X; Zhang C; Wang X; Cui C; Cui H; Zhu B; Chen A; Zhang L; Xin J; Fu Q; Dionigi G; Sun H
Endocr Relat Cancer; 2023 Mar; 30(3):. PubMed ID: 36606578
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid carcinoma.
Feng Z; Chen R; Huang N; Luo C
Life Sci; 2020 Mar; 244():117298. PubMed ID: 31953163
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of DLG1-AS1 distinguished papillary thyroid carcinoma from benign thyroid nodules.
He T; Wang H; Sun J; Wu J; Gong F; Li S; Wang H; Li Y
BMC Endocr Disord; 2019 Nov; 19(1):122. PubMed ID: 31718630
[TBL] [Abstract][Full Text] [Related]
12. LncRNA DNAJC3-AS1 promotes the biological functions of papillary thyroid carcinoma via regulating the microRNA-27a-3p/CCBE1 axis.
Ni T; Li Y; Guo D; Tan L; Xiao Z; Shi Y
Cell Biol Int; 2023 Mar; 47(3):539-547. PubMed ID: 36583660
[TBL] [Abstract][Full Text] [Related]
13. LncRNA FEZF1-AS1 promoted chemoresistance, autophagy and epithelial-mesenchymal transition (EMT) through regulation of miR-25-3p/ITGB8 axis in prostate cancer.
Wang ZH; Wang JH; Wang KQ; Zhou Y; Wang J
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2281-2293. PubMed ID: 32196579
[TBL] [Abstract][Full Text] [Related]
14. lncRNA GAS8-AS1 genetic alterations in papillary thyroid carcinoma and their clinical significance.
Zhou DL; Liu Q; Xu BH; Li Y; Su X; Ye ZL; Zhang X; Peng JL; Deng L; Tang T; Shao Q; Ma JJ; Yang XH; He CY
Cancer Biomark; 2020; 29(2):255-264. PubMed ID: 32675393
[TBL] [Abstract][Full Text] [Related]
15. Long Non-Coding RNA NNT-AS1 Contributes to Cisplatin Resistance via miR-1236-3p/ATG7 Axis in Lung Cancer Cells.
Wang H; Guo M; Ding D; Yang F; Chen Z
Onco Targets Ther; 2020; 13():3641-3652. PubMed ID: 32431515
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of the long non-coding RNA FOXD2-AS1 is correlated with tumor progression and metastasis in papillary thyroid cancer.
Li H; Han Q; Chen Y; Chen X; Ma R; Chang Q; Yin D
Am J Transl Res; 2019; 11(9):5457-5471. PubMed ID: 31632522
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA ZFAS1 promotes progression of papillary thyroid carcinoma by sponging miR-590-3p and upregulating HMGA2 expression.
Tong H; Zhuang X; Cai J; Ding Y; Si Y; Zhang H; Shen M
Onco Targets Ther; 2019; 12():7501-7512. PubMed ID: 31571903
[TBL] [Abstract][Full Text] [Related]
18. E2F1-Induced Overexpression of Long Noncoding RNA SBF2-AS1 Promotes Non-Small-Cell Lung Cancer Metastasis Through Regulating miR-362-3p/GRB2 Axis.
Wang A; Wang J
DNA Cell Biol; 2020 Jul; 39(7):1290-1298. PubMed ID: 32364763
[TBL] [Abstract][Full Text] [Related]
19. microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer.
Li P; Xing W; Xu J; Yuan D; Liang G; Liu B; Ma H
Stem Cell Res Ther; 2019 May; 10(1):144. PubMed ID: 31113460
[TBL] [Abstract][Full Text] [Related]
20. Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway.
Xia F; Chen Y; Jiang B; Du X; Peng Y; Wang W; Huang W; Feng T; Li X
Cell Physiol Biochem; 2018; 50(5):1659-1672. PubMed ID: 30384358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
